The chart shows the distribution of publications by all Research.com ranked scientists in the field of Engineering and Technology in 2026. The highlighted bar marks where A.R. Raffray sits on this spectrum.
This scientist: 161 publications — 32nd percentile
32% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 804 publications or more.
The chart shows the D-index (discipline H-index) distribution of Engineering and Technology scientists ranked by Research.com in 2026. The highlighted bar marks where A.R. Raffray sits on this spectrum.
This scientist: 31 D-Index — 2nd percentile
2% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 107 D-Index or more.
A.R. Raffray is affiliated with the University of California, San Diego in the United States. Their research spans multiple interconnected fields, primarily focusing on engineering, materials science, and physics and astronomy.
The scientist's work covers several subfields, including materials chemistry, aerospace engineering, nuclear and high energy physics, biomedical engineering, and energy engineering and power technology.
Raffray's research topics include fusion materials and technologies, magnetic confinement fusion research, superconducting materials and applications, nuclear materials and properties, nuclear reactor physics and engineering, spacecraft and cryogenic technologies, and hybrid renewable energy systems.
Their recent published work includes the paper titled First wall power flux management during plasma current ramp-up on ITER, which appeared in 2022 in the journal Nuclear Fusion.
Frequent co-authors associated with Raffray's publications include:
Their work has primarily appeared in the journal Nuclear Fusion, which is the frequent venue for their publications.
R.A. Pitts;S. Carpentier;F. Escourbiac;T. Hirai
Farrokh Najmabadi;A. Abdou;L. Bromberg;T. Brown
A. R. Raffray;R. Jones;G. Aiello;M. Billone
A.R. Raffray;J. Schlosser;M. Akiba;M. Araki
T. Ihli;T.K. Basu;L.M. Giancarli;S. Konishi
F. Najmabadi;A. R. Raffray;S. I. Abdel-Khalik;L. Bromberg
A.R Raffray;M Akiba;V Chuyanov;L Giancarli
A. R. Raffray;B. Calcagno;P. Chappuis;Zhang Fu
A. R. Raffray;R. Nygren;D. G. Whyte;S. Abdel-Khalik
M.S. Tillack;A.R. Raffray;X.R. Wang;S. Malang
V. Barabash;G. Federici;R. Matera;A. R. Raffray
N.B. Morley;Yutai Katoh;Siegfried Malang;Bruce A Pint
A.R Raffray;L El-Guebaly;S Gordeev;S Malang
J D Sethian;D G Colombant;J L Giuliani;R H Lehmberg
S. Malang;A.R. Raffray;N.B. Morley
A.René Raffray;Gianfranco Federici
G. Federici;A.R. Raffray;M.A. Abdou
A. R. Raffray;L. El-Guebaly;S. Malang;X. R. Wang
Mario Merola;Frederic Escourbiac;Alphonse Rene Raffray;Philippe Chappuis
Gianfranco Federici;A.René Raffray
If you think any of the details on this page are incorrect, let us know.
Oswaldo Cruz Foundation
UCB Pharma (Belgium)
Ludwig-Maximilians-Universität München
Inserm
New York University
Stanford University
University of Edinburgh
University of Nottingham
Clark University
Delft University of Technology
University of Edinburgh
Eindhoven University of Technology
Google (United States)
ETH Zurich
European Institute of Oncology
AARP
